IPAD-DB ID | S00161 |
Name | Fast green FCF |
Category | Synthetic compounds |
2D Structure |
|
3D Structure | |
Molecular Formula | C 3 7 H 3 4 N 2 N a 2 O 1 0 S 3 |
Molecular Weight | 808.9g/mol |
IUPAC Name | disodium;2-[[4-[ethyl-[(3-sulfonatophenyl)methyl]amino]phenyl]-[4-[ethyl-[(3-sulfonatophenyl)methyl]azaniumylidene]cyclohexa-2, 5-dien-1-ylidene]methyl]-5-hydroxybenzenesulfonate |
InChI | InChI=1S/C37H36N2O10S3.2Na/c1-3-38(24-26-7-5-9-33(21-26)50(41, 42)43)30-15-11-28(12-16-30)37(35-20-19-32(40)23-36(35)52(47, 48)49)29-13-17-31(18-14-29)39(4-2)25-27-8-6-10-34(22-27)51(44, 45)46;;/h5-23H, 3-4, 24-25H2, 1-2H3, (H3, 41, 42, 43, 44, 45, 46, 47, 48, 49);;/q;2*+1/p-2 |
InChIKey | RZSYLLSAWYUBPE-UHFFFAOYSA-L |
Canonical SMILES | CCN(CC1=CC(=CC=C1)S(=O)(=O)[O-])C2=CC=C(C=C2)C(=C3C=CC(=[N+](CC)CC4=CC(=CC=C4)S(=O)(=O)[O-])C=C3)C5=C(C=C(C=C5)O)S(=O)(=O)[O-].[Na+].[Na+] |
PubChem CID | 16887 |
DrugBank Accession Number | - |
CAS Registry Number | - |
Molecular Weight(Computed by SwissADME) | 808.85 |
Hac(Computed by SwissADME) | 54 |
Volume(Computed by ADMETlab 2.0) | 726.329 |
Density(Computed by ADMETlab 2.0) | 1.049 |
nRing(Computed by ADMETlab 2.0) | 5 |
MaxRing(Computed by ADMETlab 2.0) | 6 |
nHet(Computed by ADMETlab 2.0) | 15 |
fChar(Computed by ADMETlab 2.0) | -2 |
nRig(Computed by ADMETlab 2.0) | 38 |
Flexibility(Computed by ADMETlab 2.0) | 0.316 |
Stero Centers(Computed by ADMETlab 2.0) | 0 |
LogS(Computed by ADMETlab 2.0) | -1.275 |
LogD(Computed by ADMETlab 2.0) | 0.718 |
logP(Computed by ADMETlab 2.0) | 1.197 |
TPSA(Computed by SwissADME) | 223.22 |
Hbond Acceptor(Computed by SwissADME) | 10 |
Hbond Donor(Computed by SwissADME) | 1 |
Rotatable Bonds(Computed by SwissADME) | 12 |
GI Absorption(Computed by SwissADME) | Low |
BBB(blood-brain barrier) Permeant(Computed by SwissADME) | No |
P-gp Substrate(Computed by SwissADME) | Yes |
CYP1A2 Inhibitor(Computed by SwissADME) | No |
CYP2C19 Inhibitor(Computed by SwissADME) | No |
CYP2C9 Inhibitor(Computed by SwissADME) | No |
CYP2D6 Inhibitor(Computed by SwissADME) | No |
CYP3A4 Inhibitor(Computed by SwissADME) | No |
log Kp(Skin Permeation)(Computed by SwissADME) | -8.07 |
Lipinski(Computed by SwissADME) | 2 |
Ghose(Computed by SwissADME) | 4 |
Veber(Computed by SwissADME) | 2 |
Egan(Computed by SwissADME) | 2 |
Muegge(Computed by SwissADME) | 2 |
Bioavailability Score(Computed by SwissADME) | 0.17 |